JSA advised Creador in an investment of Rs. 250 Crores, through its affiliate Sundara (Mauritius) Limited in Shriji Polymers (India) Limited (“Company”). The transaction involved the acquisition of shares from TATA Capital Heatlhcare Fund, Beta TC Holdings Pte Ltd and HBM Healthcare Investments (Cayman) Ltd and some of the promoters. The transaction gave a complete exit to the existing investors (TATA Capital, Beta and HBM).
Shriji is a leading manufacturer of rigid plastic packaging for regulated pharma industry offering comprehensive portfolio of products across bottles, caps and specialty products to leading global generic pharmaceutical manufacturers.
Creador is a private equity firm specializing in growth capital investments, in the field of financial services, pharma, healthcare, retail etc.
The JSA Team comprised Partners – Aarthi Sivanandh and Bhavana Alexander, Associates – Saibarath Seshadri, Pavithra Manivannan and Bhargavi Ravi. Akshat Jain (Partner) and Girik Bhalla (Associate) assisted with the regulatory aspect of the due diligence. Kumaramangalam Vijay, Partner, assisted with tax advisory.